• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BRANY, ACRES form strategic alliance

BRANY, ACRES form strategic alliance

December 11, 2013
CenterWatch Staff

The Biomedical Research Alliance of New York (BRANY), a national organization providing expedited end-to-end solutions for clinical trials support to sponsors and investigators, and the nonprofit Alliance for Clinical Research Excellence and Safety (ACRES), have announced a strategic alliance.

One of its first initiatives is a collaboration to develop and test standards for clinical research sites and principal investigators as part of the ongoing ACRES Site Accreditation and Standards Initiative (SASI).

BRANY, founded in 1998, includes NYU School of Medicine, Montefiore Medical Center, Mount Sinai School of Medicine, North Shore-Long Island Jewish Health System and a network of more than 200 affiliated clinical research sites.

“BRANY and ACRES have a shared interest in developing and promoting standards that will enhance the quality and efficiency of clinical trials and protect clinical trial participants,” said Kimberly Irvine, CIP, executive vice president and chief operating officer of BRANY. “Our organization has been offering research site certification as part of its vetting process for years, and this has helped research sponsors and CROs more easily identify high-performing research sites and principal investigators for their studies.”

The two groups said although there are comprehensive laws, regulations and guidelines covering virtually every aspect of running and managing clinical trials, third-party accreditation has not been used effectively to ensure the highest standards for research sites and investigators. Research sponsors and CROs are increasingly relying on centralized vetting processes to identify and select sites. An effective site-oriented accreditation process will facilitate this by recognizing and rewarding excellence.

“ACRES is a collaborative effort to build a global system for clinical research that serves the interests of all stakeholders,” said Greg Koski, Ph.D., M.D., president and co-founder of ACRES. “A fundamental requirement of this systems approach is to develop uniform, comprehensive standards to promote professionalism and operational excellence at clinical trial sites worldwide.”

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing